Source:
https://cipollettidigital.com.ar/co...mados-en-siete-provincias-de-viruela-del-mono
Health reported 170 confirmed cases in seven provinces of monkeypox
Seven provinces concentrate the 170 confirmed cases of monkeypox in Argentina, as reported today by the Ministry of Health in its Epidemiological Bulletin.
According to this information, which compiles the information available up to August 31, 40 cases were reported in the province of Buenos Aires, 118 in the Autonomous City of Buenos Aires, 5 in Córdoba, 1 in Mendoza, 1 in Neuquén, 2 in Río Negro and 3 in Santa Fe.
In this way, 69.4% of the cases reside in CABA, 23.5% in the province of Buenos Aires, and 2.9% in Córdoba.
The Ministry of Health explained that, of the 170 confirmed cases of monkeypox in our country, 41 had a travel history prior to the onset of symptoms: 26 from Europe, 8 from North America, 6 from South America, and an unspecified trip.
Of the 129 cases without a history of travel, information is available on 92 confirmed cases, for which there is information on a history of physical contact with suspected/confirmed/symptomatic cases, physical contact with a traveler, multiple/occasional relationships.
99.41% of the confirmed cases correspond to people of legal male sex and one to female and transgender women, with an average age of 35 years, a minimum of 18 years and a maximum of 61.
The most affected population, to date, is made up of men who have sex with other men (90 out of 170 reported it this way), however, it is important to remember that the Ministry stressed that monkeypox "can affect anyone who enters in contact with a person sick with monkeypox, especially if they have direct physical contact, or with contaminated materials".
The report also specified that the cases per week show a gradual and sustained increase in confirmed cases from week 26, and a more pronounced increase from week 31.
In addition, most of the cases in the current outbreak presented mild symptoms of the disease, characterized mainly by the presence of a skin rash and in several cases few lesions in different places (genitals, perianal, hands, torso and face).
Other presenting symptoms were lymphadenopathy (glands that increase in size), fever greater than 38.5°, myalgia, fatigue, headache, and back pain.
They also reported that to date no serious cases, hospitalizations or deaths have been reported, but that it can cause serious illness in certain risk groups (young children, pregnant women and immunosuppressed people).
According to data provided by the World Health Organization (WHO), as of August 24, a total of 42,800 confirmed cases of monkeypox were reported in the world in 124 countries, and 12 deaths, while worldwide, 5,100 cases were reported in the last seven days.
In the Region of the Americas, from August 11 to 17, there were 18,659 confirmed cases, representing an increase of 34% compared to the previous week.
For its part, two deaths were reported in the region, the first in Brazil and the second in Ecuador (both were male and had pre-existing pathologies).
In addition, they detailed that in the last three weeks the proportion of female cases has been increasing, and that five countries reported 46 confirmed cases with people under 18 years of age (Brazil, Canada, Ecuador, Mexico and Peru).
Meanwhile, 82% of the cases in the Region of the Americas, with available information, are cases of local transmission.
For its part, as of August 24, Africa reported 404 cases; the Region of the Americas, 21,120; Europe, 21,098; the Western Pacific Region, 121; the Eastern Mediterranean Region, 36; and the South-East Asia Region, 14.
On July 23, the WHO, due to the rapid spread of the virus in at least 75 countries and territories, declared that the current outbreak of smallpox constitutes a Public Health Emergency of International Importance, and urged "intensify epidemiological surveillance measures identify cases and their contacts and implement control measures".
